Development & Clinical Application of K-PaC Registry Version 2.0

Development and clinical use of pancreatic cancer registry * Development of K-PaC Registry v.2.0: Retrospective data integration from 2010 to 2022 and prospective data collection from more than 811 enrolled patients from 2023 to 2029 * Creation of clinical evidence (RWE) based on pancreatic cancer real-world data (RWD): 3 or more

NCT Number	NCT07171515
Lead Sponsor	National Cancer Center, Korea
Conditions	Pancreatic Cancer
Enrollment	6,923 participants
Start Date	2023-01-02
Primary Completion	2029-12-31 (estimated)
Study Completion	2030-12-31 (estimated)
Updated on ClinicalTrials.gov	2025-09-12